A systematic review and meta-analysis of the role ofABCC2variants on drug response in patients with epilepsy

ABCC2 Polymorphisms and Haplotype are Associated with Drug Resistance in Chinese Epileptic Patients

(2012) Jian Qu et al.   CNS Neuroscience & Therapeutics

Revising and refining the epilepsy classification system: Priorities from a developing world perspective

(2012) Gretchen L. Birbeck   EPILEPSIA

Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs

(2012) Sandeep Grover et al.   Pharmacogenetics and Genomics

Lack of association between ABCC2 gene variants and treatment response in epilepsy

(2012) Eva Hilger et al.   PHARMACOGENOMICS

Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport

(2011) Heidrun Potschka   ADVANCED DRUG DELIVERY REVIEWS

Biomarkers for antiepileptic drug response

(2011) Tracy A Glauser   Biomarkers in Medicine

Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy

(2011) Mike Ufer et al.   Pharmacogenetics and Genomics

Gene-wide tagging study of the association betweenABCC2,ABCC5andABCG2genetic polymorphisms and multidrug resistance in epilepsy

(2011) Patrick Kwan et al.   PHARMACOGENOMICS

Pharmacogenomics and epilepsy: the road ahead

(2011) Gianpiero L Cavalleri et al.   PHARMACOGENOMICS

Association ofABCB1gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis

(2011) Batoul Sadat Haerian et al.   PHARMACOGENOMICS

Predisposition to epilepsy-Does the ABCB1 gene play a role?

(2010) Laila Nurmohamed et al.   EPILEPSIA

Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy

(2010) Carlos Luna-Tortós et al.   NEUROPHARMACOLOGY

Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment

(2010) Sandeep Grover et al.   PHARMACOGENOMICS

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function

(2010) S Laechelt et al.   PHARMACOGENOMICS JOURNAL

Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: A meta-analysis

(2009) Facundo Garcia Bournissen et al.   EPILEPSIA

Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

(2009) Patrick Kwan et al.   EPILEPSIA

Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy

(2009) Dong Wook Kim et al.   EPILEPSY RESEARCH

Challenges in the management of epilepsy in resource-poor countries

(2009) Kurupath Radhakrishnan   Nature Reviews Neurology

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

(2009) Mike Ufer et al.   Pharmacogenetics and Genomics

Epilepsy pharmacogenetics

(2009) Dalia Kasperavičiūtė et al.   PHARMACOGENOMICS

ABCC2haplotype is not associated with drug-resistant epilepsy

(2008) Takayuki Seo et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY